In a 34-month prospective study to determine the prevalence of Staphylococcus aureus small colony variants (SCVs) in cystic fibrosis (CF) patients, S. aureus SCVs or SCVs plus normal S. aureus were recovered from 26 of 78 patients; 27 patients harbored only normal S. aureus. By pulsed-field gel electrophoresis, clonal identity was demonstrated of SCV and normal strains isolated at the same time and of multiple S. aureus SCV and normal strains in consecutive specimens from individual patients. All S. aureus SCVs were resistant to antifolate antibiotics, while the corresponding parent strains were susceptible, and in 11 of 12 SCV/normal pairs, gentamicin was less active against S. aureus with the SCV phenotype than against the normal isolate. Analysis of the underlying auxotrophism of SCVs revealed hemin, thymidine, and/or menadione dependencies. Thus, S. aureus SCVs are highly prevalent in respiratory secretions of CF patients, persist over extended periods, and may contribute to S. aureus persistence in CF patients.
Cystic fibrosis (CF) is an autosomal recessive genetic disorall been implicated in bronchial colonization and may also contribute to the persistence of the microorganisms in the lung der, caused by a mutation in the cystic fibrosis gene affecting the cAMP-regulated transmembrane Cl 0 channel, resulting in tissue. Persistence of S. aureus in invasive infections other than CF, however, has recently been associated with the isolation abnormal respiratory secretions [1] . CF is characterized by severe bronchopulmonary infections and inflammation of the of S. aureus subpopulations with a small colony variant (SCV) phenotype [6, 7] . In contrast to S. aureus exhibiting typical airways, with a characteristic microflora (i.e., Staphylococcus aureus and Pseudomonas aeruginosa) contributing to progrescolony size, pigmentation, and hemolysis on Columbia agar (herein referred to as ''normal'' S. aureus), S. aureus SCV sive and ultimately fatal lung disease [2] . While in the preantibiotic era, lung infection due to S. aureus was the leading cause organisms grow as nonhemolytic, nonpigmented, and very small colonies and produce greatly reduced amounts of a-toxin of death, treatment with efficient antistaphylococcal compounds and prophylactic therapy now effectively controls acute and, consequently, have been shown to intracellularly persist in in vitro systems [8] . Decreased susceptibility of SCVs may infections. Once colonized, however, often S. aureus cannot be cleared from the bronchial system despite the use of antimicontribute to their isolation (typically after long-term antimicrobial therapy) because of selection within the patient. crobials with high staphylocidal activity [3] .
The pathogenesis of staphylococcal infection in CF patients We hypothesized that the recovery of S. aureus over long periods in CF patients, in spite of antibiotic therapy, may be is complex and incompletely understood. The decreased viscoelastic properties of mucus with reduced clearance of thickened the result of a metabolic alteration resulting in expression of the SCV phenotype. To address this hypothesis, special culture secretions [1] , increased bacterial adherence to airway epithelial cells [4] , or a suggested receptor for pathogenic bacteria and identification procedures for determination of SCV prevalence had to be used, since S. aureus SCVs may be easily on the apical surface of epithelial cells of CF patients [5] have missed during microbiologic examination of bronchial secretions from CF patients because of their fastidious growth characteristics and the frequent presence of P. aeruginosa. Further-JID 1998; 177 (April) however, if patients were too young or no bronchial secretions h of incubation. Likewise, for determination of double auxotrophy, disks were tested on CDM agar supplemented with 100 mg of were produced, throat swabs were taken.
Culture techniques. Specimens were cultured on Columbia thymidine/mL, 10 mg of menadione/mL, or 1 mg of hemin/mL; for determination of triple auxotrophy, on CDM agar supplemented agar (Becton Dickinson, Heidelberg, Germany) for gram-positive cocci, on endo agar (Merck, Darmstadt, Germany) (35ЊC for 48 with 100 mg of thymidine/mL plus 10 mg of menadione/mL, 100 mg of thymidine/mL plus 1 mg of hemin/mL, or 10 mg of menadih) for gram-negative rods, on chocolate agar (Mast, Reinfeld, Germany) (24-48 h at 35ЊC with CO 2 ) for Haemophilus influenzae, one/mL plus 1 mg of hemin/mL; and for determination of combined auxotrophism, on CDM agar supplemented with 100 mg of thymiand on Schaedler (Becton Dickinson) and brain-heart infusion (BHI; Merck) agar with 5% NaCl (anaerobically at 35ЊC for 48 dine/mL, 10 mg of menadione/mL, and 1 mg of hemin/mL. Intracellular persistence assay. The intracellular persistence h) to suppress P. aeruginosa and to support growth of S. aureus and SCVs of S. aureus. assay was done as described [8] with some modifications. Aortic bovine endothelial cell monolayers were grown in Dulbecco's SCV identification. All pathogens from BHI and Schaedler agar were isolated in parallel on Columbia agar (24 h at 35ЊC) modified Eagle medium (DMEM; Sigma Aldrich) with 10% bovine calf serum in 24-well tissue culture plates (Nunc, Roskilde, and on Schaedler agar (24 h at 35ЊC with CO 2 ). Very small, nonpigmented, nonhemolytic colonies on Columbia agar were suspicious Denmark) to confluence (2 1 10 5 cells/well). Overnight BHI broth cultures of bacteria were washed, adjusted to a concentration of for SCVs if they grew nearly normally on Schaedler agar. All SCVs were identified to be S. aureus with catalase, tube coagulase 10 7 bacteria/mL, and added to the monolayers. The infected monolayers were incubated for 3.5 h at 37ЊC with 5% CO 2 to allow (bioMérieux, Marcy l'Etoile, France), Api ID 32 Staph (bioMér-ieux), and Pastorex Staph plus (Sanofi Pasteur, Marnes-la-Coadhesion and intracellular uptake of the bacteria. Then the monolayers were washed three times with DMEM and 10% calf serum quette, France). Presence of the S. aureus-specific nuc gene [9] was tested by polymerase chain reaction [10] to confirm the identito remove nonattached organisms. Next, 1 mL of DMEM with 10 mg of lysostaphin/mL was added to remove extracellular bacteria. fication of S. aureus.
Genotypic analysis. To examine the clonal identity of phenoIncubation in the presence of lysostaphin was continued for 20 min, 24 h, and 48 h. At these time points, the monolayers were typically normal and SCV S. aureus isolates, we analyzed these strains with pulsed-field gel electrophoresis (PFGE) as described washed three times with DMEM to remove lysostaphin. Endothelial cells were disrupted by addition of 1 mL of sterile water, and [11], except for the use of BHI broth, because SCVs do not grow well in tryptic soy broth (which is a medium containing fewer intracellular organisms were released. Aliquots (100 mL) of serial dilutions in sterile water were plated on BHI agar to determine nutrients).
Susceptibility testing. Susceptibility for normal and S. aureus the number of colony-forming units (cfu). aureus by Api Staph ID, and agglutinated in Pastorex Staph plus while the normal isolates (except 1 methicillin-resistant S. aureus clone) were trimethoprim-sulfamethoxazole -susceptitest. The difference of normal and S. aureus SCV is exemplified in table 1 in a subset of SCV and normal S. aureus pairs with ble. Four of 38 clones were resistant against gentamicin. The methicillin-resistant isolate was also resistant against erythroidentical PFGE profiles recovered from 6 patients with persistent SCV colonization in the same bronchial secretion. The nuc gene mycin, lincomycin, gentamicin, netilmicin, and trimethoprimsulfamethoxazole. Intermediate susceptibility was found in 14 was demonstrated by polymerase chain reaction in all SCVs. PFGE-revealed bands of S. aureus and SCV strains with the clones for gentamicin, 3 clones for ciprofloxacin, and 2 clones for cefaclor. All other strains tested were susceptible to imisame profile were considered to be clonal [17] . In 2 patients, PFGE bands of S. aureus DNA were identical, suggesting crosspenem, cefazolin, cefotaxime, erythromycin, clindamycin, chloramphenicol, ofloxacin, vancomycin, and teicoplanin. For contamination, whereas all of the other strains differed between patients. Differences in numbers or size of restriction fragments MIC determination, Etest with blood-containing medium yielded results similar to those obtained by conventional miwere compatible with one genetic event. In 16 of 19 patients with persistent SCV colonization, restriction profiles of SCV and crodilution broth MIC testing using BHI agar, but Etest generally allowed a more discriminatory MIC determination for normal S. aureus from each patient revealed clonality of the strains. In 5 of these patients, in addition to the clonal SCVSCVs and was therefore further used. All normal S. aureus isolates except the methicillin-resistant isolate were trimethonormal pair, a second normal or SCV S. aureus strain could be isolated. Two patients lost a persistent SCV strain, which was prim-sulfamethoxazole -susceptible (MIC õ0.125), while all SCVs were trimethoprim-sulfamethoxazole -resistant (MIC isolated at the beginning of the study, during 4 and 12 months and started to harbor a second SCV/normal pair for 3 and 26 ú32). Of 12 SCV-normal strain pairs, 11 of 12 SCVs had higher gentamicin MICs than did their corresponding normal months, respectively. One patient harbored 3 different S. aureus SCV clones in his respiratory specimens. Three of 19 patients S. aureus strain (table 2) . All 26 patients with SCVs had received trimethoprim-sulfawith persistent SCV colonization had only SCVs and no normal S. aureus in their specimens. Restriction profiles of several conmethoxazole prophylaxis, whereas only 10 of 27 patients with normal S. aureus received this treatment (P õ .001). Patients secutively cultured normal and SCV S. aureus isolates of 1 of the 19 patients with persistent SCV colonization (patient 3 in with SCVs were treated longer with trimethoprim-sulfamethoxazole (median, 23.5 months) than were patients without SCVs table 1) are given in figure 1.
PFGE analysis revealed 38 different S. aureus clones in 26 but with normal S. aureus (median 18 months), but this difference was not significant. After trimethoprim-sulfamethoxazole patients with SCV carriage. By agar diffusion, resistance against penicillin was found in 27 of 38 clones. In addition, all was changed to another antimicrobial, in 11 patients it was possible to further isolate SCVs (3 -32 months). SCV isolates were trimethoprim-sulfamethoxazole -resistant, Auxotrophism for hemin could be demonstrated in 10, for lar persistence of S. aureus SCV strains with their decreased production of a-toxin compared with normal S. aureus strains, menadione in 2, and for thymidine in 41 SCV strains. Double auxotrophy for thymidine plus hemin was found in 25 strains. the intraendothelial cell persistence assay was done with a clinical isogenic normal and S. aureus SCV isolate pair. S. NAD / factor did not influence the growth. Ingestion of a-toxin -producing S. aureus by endothelial aureus isolates were allowed to invade endothelial cells for 3.5 h. After an additional 20 min of incubation in the presence of cells results in damage of the endothelial cell monolayer [18]; thus, S. aureus is released to the extracellular milieu and is lysostaphin, subsequent removal of lysostaphin by washing, and disruption of the endothelial cells with sterile water, 0.59% lysed by extracellular lysostaphin. To determine the intracellu- [6, 23] . As a result of these in vitro and clinical observations, the following hallmarks of S. aureus SCVs have emerged [7] : S. aureus SCVs are associated with refractory and persistent infection, emergence of S. aureus SCVs is favored by prior exposure to antimicrobials, and the type of phenotypic variation likely reflects impaired respiratory metabolism resulting from alterations in the electron transport system, with the consequence of decreased ATP production and reduced membrane potential. basis. The frequent isolation and persistence of S. aureus in our CF patients, as demonstrated by clonal identity in PFGE, confirms these observations, while the high prevalence of SCV and 10.00% of normal and S. aureus SCV, respectively, were isolates adds evidence for a specific role of these variants in recovered from the intracellular site. The ratio of viable organchronic staphylococcal disease. It has been argued that S. isms of SCV versus normal phenotype recovered after 24 h aureus SCVs may intracellularly persist because of their greatly and 48 h of coincubation with lysostaphin was ú1000-fold reduced a-toxin production and thus may escape host defense and ú100-fold, respectively (figure 2; P õ .05, unpaired t and antibiotic therapy [8, 18] . Interestingly, all the clinical test).
SCV isolates characterized in this study were phenotypically atoxin -negative, and their potential for intracellular persistence could be exemplified with 1 SCV-normal S. aureus strain pair.
Discussion
On the other hand, it recently has been demonstrated that uptake of P. aeruginosa by mutant cystic fibrosis transmembrane reguIn this study, for the first time, a high prevalence of S. aureus SCVs in specimens from a defined patient population could be lator (CFTR) epithelial cells is decreased in vitro [26] . Accordingly, it has been hypothesized that phagocytosis of bronchial demonstrated. Because of the atypical colony morphology of these variants, prerequisite for this finding was the application pathogens by these nonprofessional phagocytes may clear bacteria from normal lung, a host defense mechanism possibly of extended conventional culture and identification techniques. Furthermore, it could be demonstrated that S. aureus SCVs impaired in CF. To delineate the role of S. aureus SCV intracellular persistence in CF disease, further studies are necessary from our CF patients exhibit profoundly decreased susceptibility against antimicrobials such as trimethoprim-sulfamethoxato examine the uptake and survival in bronchial epithelial cells. S. aureus SCVs can be selected by antimicrobials, as shown zole and aminoglycosides compared with that of isogenic S. aureus isolates with the normal phenotype. Finally, it could be by exposure of normal S. aureus to subinhibitory concentrations of gentamicin [8] . In vivo, emergence of SCVs has been shown that the recovery of S. aureus SCVs in consecutive patient specimens over extended time spans reflects persistence strongly associated with antibiotic use [6, 7, 23] ; however, SCVs may also be isolated after prolonged antibiotic-free interof clonally identical strains and that parallel or consecutive cultures of phenotypically different S. aureus populations occur vals [6, 7] . All of our patients with SCVs received trimethoprim-sulfamethoxazole prophylaxis, and 11 of 19 patients with in spite of clonal identity of the isolates.
SCVs of S. aureus have been well described for ú40 years persistent SCV colonization received interventional aminoglycoside therapy. However, and in contrast to previously reported [19, 20] , yet their significance has been limited by the fact that their occurrence in clinical specimens has been rarely reported thymidine-dependent S. aureus variants [27] , in addition to thymidine auxotrophism, both hemin and menadione auxo- [7] . Renewed interest in S. aureus SCV pathogenicity gave insight into selection for and persistence of S. aureus SCVs in trophism were demonstrated in our study. Notably, SCVs were isolated in our patients even after extended trimethoprim-sulfaeukaryotic cells [8, 21] and the underlying metabolic alteration [7, 22] . Recently, a site-directed S. aureus hemB mutant was methoxazole -free intervals (3 -31 months) and remained in
